Comment on: Hasselgren K, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448
- PMID: 35129508
- PMCID: PMC9018892
- DOI: 10.1097/SLA.0000000000005262
Comment on: Hasselgren K, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448
Conflict of interest statement
The authors report no conflicts of interest.
Comment in
-
Response to Comment on: Hasselgren K, et al ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442-448.Ann Surg. 2022 Nov 1;276(5):e632-e633. doi: 10.1097/SLA.0000000000005268. Epub 2021 Oct 20. Ann Surg. 2022. PMID: 35129514 No abstract available.
Comment on
-
ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.Ann Surg. 2021 Mar 1;273(3):442-448. doi: 10.1097/SLA.0000000000003701. Ann Surg. 2021. PMID: 32049675 Clinical Trial.
References
-
- Hasselgren K, Rosok BI, Larsen PN, et al. ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO. Ann Surg. 2021;273(3):442–448. - PubMed
-
- Sandstrom P, Rosok BI, Sparrelid E, et al. ALPPS Improves Resectability Compared With Conventional Two-stage Hepatectomy in Patients With Advanced Colorectal Liver Metastasis: Results From a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial). Ann Surg. 2018;267(5):833–840. - PMC - PubMed
-
- Knobloch K, Gohritz A, Vogt PM. CONSORT and QUOROM statements revisited: standards of reporting of randomized controlled trials in general surgery. Ann Surg. 2008;248(6):1106–1107; discussion 1107-1108. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
